News Stories

 

COVID-19 Related Funding Opportunities
UC Davis COVID-19 Research Accelerator Fund Call for Proposals and Application Guidelines

UC Davis COVID-19 Research Accelerator Fund Call for Proposals and Application Guidelines

Program Overview Update: Funds for this program have been exhausted…
Novel Coronavirus SARS-CoV-2.

New Working Group Advances COVID-19 Research at UC Davis

By Lisa Howard The Office of Research has launched a COVID-19…
Campus Guidance on Reducing On-Campus Research Activities Due to COVID-19 (March 17, 2020)

Campus Guidance on Reducing On-Campus Research Activities Due to COVID-19 (March 17, 2020)

  A Message from Vice Chancellor for Research Prasant Mohapatra…
Lifeng Lai, Eric Kurzrock and Soheil Ghiasi

Wearable Device Assists People with Spinal Cord Injuries

By Lisa Howard UC Davis medical and engineering experts are…
Sierra Biopharma is Developing Antigen-Specific Therapy Targeting Autoimmune Diseases

Sierra Biopharma is Developing Antigen-Specific Therapy Targeting Autoimmune Diseases

Sierra Biopharma, a biotechnology startup founded on intellectual…
Mouse Biology Program Joins the Office of Research

Mouse Biology Program Joins the Office of Research

As the Mouse Biology Program (MBP) begins its third decade…
UC Davis Associate Professor Justin Siegel.

University Startup PvP Biologics Acquired by Takeda Pharmaceutical Company

By Lisa Howard PvP Biologics, a startup formed around technology…
Innovator of the Year Award: Nominations Due March 12, 2020
Office of Research Releases 2020 Strategic Plan